Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Clinical and Translational Gastroenterology
|
July 12, 2019
A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
R K Kelley, E Gane, E Assenat, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study
Y J Kim, P Merle, R S Finn, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2006
Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study
C Bonny, H Fontaine, T Poynard, et al.
BMC Geriatrics
|
October 12, 2019
Prevalence of Potentially Inappropriate Medication use in older drivers
Guohua Li, Howard F Andrews, Stanford Chihuri, et al.
ESMO Open
|
May 28, 2025
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma
R S Finn, M Kudo, P Merle, et al.
Journal of Hepatology
|
March 22, 2026
Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: Results from the 2025 French Genomic Medicine Initiative
C Campani, P Laurent Puig, F Villeret, et al.
Physical Review Letters
|
January 22, 2002
Neutral pion threshold production at Q(2) = 0.05 GeV(2)/c(2) and chiral perturbation theory
H Merkel, P Bartsch, D Baumann, et al.
Physical Review Letters
|
April 17, 2002
Measurement of the beam-helicity asymmetry in the p((-->)e,e'p)pi(0) reaction at the energy of the Delta(1232) resonance
P Bartsch, D Baumann, J Bermuth, et al.
Oncoimmunology
|
August 16, 2019
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
M Moehler, J Heo, H C Lee, et al.
Techniques in Coloproctology
|
January 10, 2024
Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice
L Spindler, I Etienney, L Abramowitz, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Clinical and Translational Gastroenterology
|
July 12, 2019
A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
R K Kelley, E Gane, E Assenat, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study
Y J Kim, P Merle, R S Finn, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2006
Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study
C Bonny, H Fontaine, T Poynard, et al.
BMC Geriatrics
|
October 12, 2019
Prevalence of Potentially Inappropriate Medication use in older drivers
Guohua Li, Howard F Andrews, Stanford Chihuri, et al.
ESMO Open
|
May 28, 2025
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma
R S Finn, M Kudo, P Merle, et al.
Journal of Hepatology
|
March 22, 2026
Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: Results from the 2025 French Genomic Medicine Initiative
C Campani, P Laurent Puig, F Villeret, et al.
Physical Review Letters
|
January 22, 2002
Neutral pion threshold production at Q(2) = 0.05 GeV(2)/c(2) and chiral perturbation theory
H Merkel, P Bartsch, D Baumann, et al.
Physical Review Letters
|
April 17, 2002
Measurement of the beam-helicity asymmetry in the p((-->)e,e'p)pi(0) reaction at the energy of the Delta(1232) resonance
P Bartsch, D Baumann, J Bermuth, et al.
Oncoimmunology
|
August 16, 2019
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
M Moehler, J Heo, H C Lee, et al.
Techniques in Coloproctology
|
January 10, 2024
Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice
L Spindler, I Etienney, L Abramowitz, et al.
Page
of 12